Gray Private Wealth LLC Sells 219 Shares of HCA Healthcare, Inc. $HCA

Gray Private Wealth LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 13.3% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,429 shares of the company’s stock after selling 219 shares during the quarter. HCA Healthcare makes up about 0.3% of Gray Private Wealth LLC’s holdings, making the stock its 25th largest holding. Gray Private Wealth LLC’s holdings in HCA Healthcare were worth $547,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Nuveen LLC acquired a new position in HCA Healthcare in the 1st quarter worth $569,217,000. Pacer Advisors Inc. boosted its position in shares of HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after buying an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD raised its position in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP bought a new stake in shares of HCA Healthcare in the first quarter worth $164,835,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.2%

HCA Healthcare stock opened at $426.81 on Friday. The stock’s 50 day moving average is $395.62 and its 200-day moving average is $371.70. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $429.43. The company has a market capitalization of $99.87 billion, a price-to-earnings ratio of 17.94, a PEG ratio of 1.34 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter last year, the business earned $5.50 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analyst Upgrades and Downgrades

Several brokerages have commented on HCA. Barclays boosted their price target on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Wells Fargo & Company lowered their price target on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $407.75.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.